OncoTherapy Science, Inc. Logo

OncoTherapy Science, Inc.

Develops targeted cancer therapies and provides TCR repertoire analysis services.

4564 | T

Overview

Corporate Details

ISIN(s):
JP3202150003
LEI:
Country:
Japan
Address:
川崎市川崎区東田町1番地2
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

OncoTherapy Science, Inc. is a biotechnology company focused on the research and development of novel cancer treatments. Founded in 2001, the company collaborates with genomics pioneer Professor Yusuke Nakamura to identify cancer-specific genes for the creation of molecular-targeted therapies, including low-molecular-weight drugs and antibody drugs. The company's mission is to develop treatments with high efficacy and minimal adverse events. In addition to its drug discovery pipeline, OncoTherapy Science offers a comprehensive T-cell receptor (TCR) repertoire analysis service, utilizing next-generation sequencing technology for detailed immunoprofiling from blood and tissue samples.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 07:32
Registration Form
有価証券届出書(組込方式)
Japanese 399.0 KB
2025-11-10 01:21
Registration Form
確認書
Japanese 8.2 KB
2025-11-10 01:20
Interim Report
半期報告書-第25期(2025/04/01-2026/03/31)
Japanese 250.0 KB
2025-06-26 03:49
Post-Annual General Meeting Information
臨時報告書
Japanese 21.9 KB
2025-06-24 09:11
Governance Information
内部統制報告書-第24期(2024/04/01-2025/03/31)
Japanese 22.8 KB
2025-06-24 09:10
Registration Form
確認書
Japanese 8.2 KB
2025-06-24 09:09
Annual Report
有価証券報告書-第24期(2024/04/01-2025/03/31)
Japanese 976.0 KB
2025-04-10 08:33
Registration Form
有価証券届出書(組込方式)
Japanese 404.8 KB
2025-02-18 01:06
Post-Annual General Meeting Information
臨時報告書
Japanese 21.4 KB
2024-11-11 01:25
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-11 01:23
Interim Report
半期報告書-第24期(2024/04/01-2025/03/31)
Japanese 272.5 KB
2024-06-28 08:58
Post-Annual General Meeting Information
臨時報告書
Japanese 22.8 KB
2024-06-25 09:30
Governance Information
内部統制報告書-第23期(2023/04/01-2024/03/31)
Japanese 22.9 KB
2024-06-25 09:29
Registration Form
確認書
Japanese 8.2 KB
2024-06-25 09:26
Annual Report
有価証券報告書-第23期(2023/04/01-2024/03/31)
Japanese 1007.8 KB

Automate Your Workflow. Get a real-time feed of all OncoTherapy Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OncoTherapy Science, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OncoTherapy Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan
4196
Neonode Inc. Logo
Licenses optical sensing and computer vision for HMI in automotive and consumer electronics.
United States of America
NEON
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France
ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia
NFM
NexGen Energy Ltd. Logo
Uranium exploration company developing a high-grade mine to supply global clean energy fuel.
United States of America
NXE
Nexxen International Ltd. Logo
End-to-end programmatic ad platform for advertisers, agencies, & publishers, specializing in video & CTV.
United States of America
NEXN
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France
ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden
NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan
2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan
4893

Talk to a Data Expert

Have a question? We'll get back to you promptly.